Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novartis sinks after second disastrous trial failure, this time of Avidity-acquired drug

In the wake of its high-profile setback in heart disease late last week, Novartis really needed a win. It didn’t get one. The Swiss pharma said Tuesday that in a late-stage ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Uganda: Mbarara Regional Referral Hospital Lacks Its Own Mortuary, Relies On Small Must Facility

[Nile Post] Mbarara Regional Referral Hospital is facing a severe health and infrastructural challenge due to the absence of its own mortuary facility, forcing the hospital to rely entirely on the…

  • Mbarara Regional Referral Hospital lacks its own mortuary.
  • Hospital relies on Mbarara University of Science and Technology mortuary.
  • Mortuary's infrastructure is ageing and failing.

More from Tuesday 8 September →